These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8231902

  • 1. Effects of oophorectomy and hormone replacement therapy on pituitary-gonadal function.
    Castelo-Branco C, Martínez de Osaba MJ, Vanrezc JA, Fortuny A, González-Merlo J.
    Maturitas; 1993 Sep; 17(2):101-11. PubMed ID: 8231902
    [Abstract] [Full Text] [Related]

  • 2. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison.
    Castelo-Branco C, Martínez de Osaba MJ, Fortuny A, Iglesias X, González-Merlo J.
    J Reprod Med; 1995 Aug; 40(8):556-60. PubMed ID: 7473451
    [Abstract] [Full Text] [Related]

  • 3. Effects of oophorectomy and hormone replacement therapy on plasma lipids.
    Castelo-Branco C, Casals E, Sanllehy C, González-Merlo J, Iglesias X.
    Maturitas; 1993 Sep; 17(2):113-22. PubMed ID: 8231903
    [Abstract] [Full Text] [Related]

  • 4. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W, Petersdorf LI, Junker R, Schulte H, Ebert C, Von Eckardstein A.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of oestrogen-induced prolactin release by medroxyprogesterone acetate.
    Castelo-Branco C, Palacios S, Martinez de Osaba MJ, Balasch J, Fortuny A, Vanrell J.
    Maturitas; 1994 Dec; 20(2-3):145-50. PubMed ID: 7715466
    [Abstract] [Full Text] [Related]

  • 6. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
    Jeppsson S, Gershagen S, Johansson ED, Rannevik G.
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
    [Abstract] [Full Text] [Related]

  • 7. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L.
    Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
    [Abstract] [Full Text] [Related]

  • 8. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women.
    Mathur RS, Landgrebe SC, Moody LO, Semmens JP, Williamson HO.
    Maturitas; 1985 Jul; 7(2):129-33. PubMed ID: 3929023
    [Abstract] [Full Text] [Related]

  • 9. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T, Uemura H, Tezuka M, Yamada M, Irahara M, Miura M, Aono T.
    Horm Res; 2001 Jul; 56(1-2):38-44. PubMed ID: 11815726
    [Abstract] [Full Text] [Related]

  • 10. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 11. Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
    Castelo-Branco C, Puerto B, Durán M, Gratacós E, Torné A, Fortuny A, Vanrell JA.
    Maturitas; 1994 May; 19(1):59-65. PubMed ID: 7935033
    [Abstract] [Full Text] [Related]

  • 12. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]

  • 13. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels.
    Serin IS, Ozçelik B, Başbuğ M, Aygen E, Kula M, Erez R.
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec 01; 99(2):222-5. PubMed ID: 11788176
    [Abstract] [Full Text] [Related]

  • 15. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1996 Sep 01; 19(8):535-41. PubMed ID: 8905477
    [Abstract] [Full Text] [Related]

  • 16. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A, Dodin S, Cédrin I, T-Lemay L.
    Clin Endocrinol (Oxf); 1995 Apr 01; 42(4):341-51. PubMed ID: 7750187
    [Abstract] [Full Text] [Related]

  • 17. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 01; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 18. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A, Baraghini F, Barbieri C, Dalla Vecchia E, Previdi AM, Di Renzo GC, Volpe A.
    Maturitas; 1982 Apr 01; 4(1):19-26. PubMed ID: 6285153
    [Abstract] [Full Text] [Related]

  • 19. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 01; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 20. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.